Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Liver Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Carcinoid Tumor 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Sarcoma, Synovial 1 Prolactinoma 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Fistula 1 Neoplasms 1 Nelson Syndrome 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Insulinoma 1 Hypoglycemia 1 Hyperinsulinism 1 Hematologic Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 27 Cisplatin 17 Oxaliplatin 16 Cytoreduction Surgical Procedures 15 Paclitaxel 12 Fluorouracil 10 Mitomycin 8 Leucovorin 8 Doxorubicin 7 Docetaxel 5 Neoadjuvant Therapy 4 Blood Specimen Collection 4 Taxes 3 Surgical Procedures, Operative 3 Chemotherapy, Adjuvant 3 Carboplatin 3 Bevacizumab 3 catumaxomab 2 Platinum 2 Palliative Care 2 Observation 2 Nivolumab 2 Mitozytrex 2 Laparoscopy 2 Interviews as Topic 2 Indocyanine Green 2 Folfox protocol 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 tremelimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Peritoneal Neoplasms × pasireotide × Clear all

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡